GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Deferred Policy Acquisition Costs

Artrya (ASX:AYA) Deferred Policy Acquisition Costs


View and export this data going back to 2021. Start your Free Trial

What is Artrya Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.